458 results on '"Zompo, M"'
Search Results
102. S-6-6 Focus on biological basis of somatoform disorders
103. Xq28 polymorphic markers in bipolar disorder
104. G6PD deficiency associates with bipolar disorder within families of G6PD-deficient bipolar patients
105. Familial rates of major affective illness in Sardinia
106. A double‐blind study of L‐sulpiride versus amitriptyline in lithium‐maintained bipolar depressives
107. An interaction between carbamazepine and fluvoxamine
108. Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity
109. Differential Interaction of 1-Methyl-4-Phenylpyridinium Ion with the Putatively Vesicular Binding Site of [3H]Tyramine in Dopaminergic and Nondopaminergic Brain Regions
110. The course of thyroid abnormalities during lithium treatment: a two‐year follow‐up study
111. Chronic administration of MPTP to monkeys: Behavioural morphological and biochemical correlates
112. Characterization of a putatively vesicular binding site for [3H]MPP+ in mouse striatal membranes
113. Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine
114. High-affinity binding of [3H]1-methyl-4-phenyl-2,3-dihydropyridinium ion to mouse striatal membranes: putative vesicular location
115. Thyroid abnormalities during lithium treatment
116. Clozapine in idiopathic Parkinson's disease
117. [3H]1-Methyl-4-Phenyl-2,3-Dihydropyridinium Ion Binding Sites in Mouse Brain: Pharmacological and Biological Characterization
118. A Double-Blind Study of Minaprine versus Amitriptyline in Major Depression
119. Association Studies in Candidate Genes: Strategies to Select SNPs to Be Tested.
120. Bipolar affective disorder and heterozygous beta-thalassemia
121. Localization of MPP binding sites in the brain of various mammalian species.
122. Linkage between X-chromosome markers and manic-depressive illness.
123. [3H]1-Methyl-4-Phenyl-2,3-Dihydropyridinium Ion Binding Sites in Mouse Brain: Pharmacological and Biological Characterization.
124. 1 -Methyl-4-Phenyl- 1,2,3,6-Tetrahydropyridine: Correspondence of Its Binding Sites to Monoamine Oxidase in Rat Brain, and Inhibition of Dopamine Oxidative Deamination In Vivo and In Vitro.
125. Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivo
126. Maternal inheritance of manic depression in hemizygotes for the G6PDMediterranean mutation Indirect evidence for Xq28 transmission in Sardinia
127. No evidence of association between dopamine D3 receptor gene and bipolar disorder in a sardinian sample
128. A reactive metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is formed in rat brain in vitro by type B monoamine oxidase.
129. Localization of MPP+ binding sites in the brain of various mammalian species
130. Cluster Headache: Clinical Efficacy of Lithium Salts in a Haemodialysis Treated Patient
131. DOPAMINE AGONISTS IN THE TREATMENT OF SCHIZOPHRENIA
132. THE USE OF DOPAMINE AGONISTS IN THE TREATMENT OF SCHIZOPHRENIA
133. Correlation with 3H-MPP+ binding sites by debrisoquine and some analogues in mouse brain
134. Differential Interaction of 1-Methyl-4-Phenylpyridinium Ion with the Putatively Vesicular Binding Site of [3H]Tyramine in Dopaminergic and Nondopaminergic Brain Regions.
135. [3H]1-Methyl-4-Phenyl-2,3-dihydropyridinium ion binding sites in mouse brain: Pharmacological and biological characterization
136. Studies in pediatrics funded by the AIFA notices 2005-2007,Gli studi in ambito pediatrico finanziati attraverso i bandi AIFA 2005-2007
137. TREATMENT OF PARKINSONʼS DISEASE WITH A DOPAMINE PARTIAL AGONIST
138. Inhibition of [3H] MPTP binding to rat brain by pargyline.
139. Behavioural And Biochemical Effects Of Flunarizine On The Dopaminergic System In Rodents
140. DOPAMINERGIC SYSTEM AND CLINICAL ASPECTS OF DEPRESSION
141. MPP+ binds to specific sites on MAO-A enzyme
142. Drugs acting on dopamine receptors: Usefulness of a perpheral blocker in Parkinson's disease
143. Mptp fails to induce lipid peroxidation in vivo
144. Properties of 3H-MPTP binding sites in human blood platelets
145. Correlation with 3H-MPP+ binding sites by debrisoquin and some analogues in mouse brain
146. TRT long-term results in lost to follow up patients: Role of the timing and of the reasons of the dropout.
147. Mania and fluvoxamine.
148. Role of dopaminergic system in migraine.
149. Evidence for dopamine receptors in the human brain mediating sedation and sleep
150. Bipolar Affective Disorder and Heterozygous β-Thalassemia.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.